Literature DB >> 33922271

Isolated Hypomethylation of IGF2 Associated with Severe Hypoglycemia Responsive to Growth Hormone Treatment.

Sarah C Grünert1, Uta Matysiak1, Franka Hodde1, Gunda Ruzaike1, Ekkehart Lausch1, Anke Schumann1, Natascha van der Werf-Grohmann1, Ute Spiekerkoetter1, Miriam Schmidts1.   

Abstract

Hypomethylation of H19 and IGF2 can cause Silver-Russell syndrome (SRS), a clinically and genetically heterogeneous condition characterized by intrauterine growth restriction, poor postnatal growth, relative macrocephaly, craniofacial abnormalities, body asymmetry, hypoglycemia and feeding difficulties. Isolated hypomethylation of IGF2 has been reported in single cases of SRS as well. Here, we report on a 19-month-old patient who presented with two episodes of hypoglycemic seizures. No intrauterine growth restriction was observed, the patient did not present with SRS-typical facial features, and postnatal growth in the first months of life was along the lower normal percentiles. Exome sequencing did not reveal any likely pathogenic variants explaining the phenotype; however, hypomethylation studies revealed isolated hypomethylation of IGF2, while the methylation of H19 appeared normal. Hypoglycemia responded well to growth hormone therapy, and the boy showed good catch-up growth. Our case demonstrates that SRS and isolated IGF2 hypomethylation should be considered early in the diagnosis of recurrent hypoglycemia in childhood, especially in combination with small gestational age and poor growth.

Entities:  

Keywords:  IGF2; Silver–Russel syndrome; growth hormone; hypoglycemia; hypomethylation

Year:  2021        PMID: 33922271     DOI: 10.3390/diagnostics11050749

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  23 in total

1.  Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype.

Authors:  Jet Bliek; Paulien Terhal; Marie-José van den Bogaard; Saskia Maas; Ben Hamel; Georgette Salieb-Beugelaar; Marleen Simon; Tom Letteboer; Jasper van der Smagt; Hester Kroes; Marcel Mannens
Journal:  Am J Hum Genet       Date:  2006-03-01       Impact factor: 11.025

2.  Segmental maternal UPD(7q) in Silver-Russell syndrome.

Authors:  T Eggermann; N Schönherr; S Jäger; C Spaich; M B Ranke; H A Wollmann; G Binder
Journal:  Clin Genet       Date:  2008-08-12       Impact factor: 4.438

3.  Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome.

Authors:  Christine Gicquel; Sylvie Rossignol; Sylvie Cabrol; Muriel Houang; Virginie Steunou; Véronique Barbu; Fabienne Danton; Nathalie Thibaud; Martine Le Merrer; Lydie Burglen; Anne-Marie Bertrand; Irène Netchine; Yves Le Bouc
Journal:  Nat Genet       Date:  2005-08-07       Impact factor: 38.330

Review 4.  New developments in Silver-Russell syndrome and implications for clinical practice.

Authors:  Miho Ishida
Journal:  Epigenomics       Date:  2016-04-12       Impact factor: 4.778

5.  Diagnosis and management of Silver-Russell syndrome: first international consensus statement.

Authors:  Emma L Wakeling; Frédéric Brioude; Oluwakemi Lokulo-Sodipe; Susan M O'Connell; Jennifer Salem; Jet Bliek; Ana P M Canton; Krystyna H Chrzanowska; Justin H Davies; Renuka P Dias; Béatrice Dubern; Miriam Elbracht; Eloise Giabicani; Adda Grimberg; Karen Grønskov; Anita C S Hokken-Koelega; Alexander A Jorge; Masayo Kagami; Agnes Linglart; Mohamad Maghnie; Klaus Mohnike; David Monk; Gudrun E Moore; Philip G Murray; Tsutomu Ogata; Isabelle Oliver Petit; Silvia Russo; Edith Said; Meropi Toumba; Zeynep Tümer; Gerhard Binder; Thomas Eggermann; Madeleine D Harbison; I Karen Temple; Deborah J G Mackay; Irène Netchine
Journal:  Nat Rev Endocrinol       Date:  2016-09-02       Impact factor: 43.330

6.  Effect of long-term growth hormone treatment on final height of children with Russell-Silver syndrome.

Authors:  Meropi Toumba; Assunta Albanese; Cristina Azcona; Richard Stanhope
Journal:  Horm Res Paediatr       Date:  2010-04-29       Impact factor: 2.852

7.  Hypoglycaemia and Russell-Silver syndrome.

Authors:  C Azcona; R Stanhope
Journal:  J Pediatr Endocrinol Metab       Date:  2005-07       Impact factor: 1.634

8.  Epigenotype-phenotype correlations in Silver-Russell syndrome.

Authors:  E L Wakeling; S Abu Amero; M Alders; J Bliek; E Forsythe; S Kumar; D H Lim; F MacDonald; D J Mackay; E R Maher; G E Moore; R L Poole; S M Price; T Tangeraas; C L S Turner; M M Van Haelst; C Willoughby; I K Temple; J M Cobben
Journal:  J Med Genet       Date:  2010-08-03       Impact factor: 6.318

9.  Biallelic loss of function variants in PPP1R21 cause a neurodevelopmental syndrome with impaired endocytic function.

Authors:  Atteeq U Rehman; Maryam Najafi; Marios Kambouris; Lihadh Al-Gazali; Periklis Makrythanasis; Abolfazl Rad; Reza Maroofian; Anna Rajab; Zornitza Stark; Jill V Hunter; Zeineb Bakey; Mari J Tokita; Weimin He; Francesco Vetrini; Andrea Petersen; Federico A Santoni; Hanan Hamamy; Kaman Wu; Fatma Al-Jasmi; Martin Helmstädter; Sebastian J Arnold; Fan Xia; Christopher Richmond; Pengfei Liu; Ehsan Ghayoor Karimiani; GholamReza Karami Madani; Sebastian Lunke; Hatem El-Shanti; Christine M Eng; Stylianos E Antonarakis; Jozef Hertecant; Magdalena Walkiewicz; Yaping Yang; Miriam Schmidts
Journal:  Hum Mutat       Date:  2018-12-25       Impact factor: 4.878

10.  A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndrome.

Authors:  Salah Azzi; Jennifer Salem; Nathalie Thibaud; Sandra Chantot-Bastaraud; Eli Lieber; Irène Netchine; Madeleine D Harbison
Journal:  J Med Genet       Date:  2015-05-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.